Quantitative Systematic Strategies LLC Immuno Gen, Inc. Transaction History

Quantitative Systematic Strategies LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 06, 2020	SELL	$2.12 - $6.8 $21,846 - $70,074	-10,305 Closed	0 $0
Q3 2019 Nov 07, 2019	SELL	$2.22 - $3.39 $22,191 - $33,886	-9,996 Reduced 49.24%	10,305 $25,000
Q2 2019 Jul 25, 2019	BUY	$1.8 - $3.3 $17,026 - $31,214	9,459 Added 87.24%	20,301 $44,000
Q1 2019 Apr 15, 2019	SELL	$2.41 - $5.91 $150,969 - $370,220	-62,643 Reduced 85.25%	10,842 $29,000
Q4 2018 Feb 12, 2019	BUY	$3.94 - $9.7 $243,042 - $598,354	61,686 Added 522.81%	73,485 $353,000
Q3 2018 Nov 14, 2018	SELL	$8.6 - $11.26 $14,663 - $19,198	-1,705 Reduced 12.63%	11,799 $112,000
Q2 2018 Aug 07, 2018	BUY	$9.52 - $12.15 $14,660 - $18,711	1,540 Added 12.87%	13,504 $131,000
Q1 2018 May 04, 2018	BUY	$6.7 - $12.95 $80,158 - $154,933	11,964 New	11,964 $126,000

1.41M

Ticker IMGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 220,712,992
Description
ImmunoGen, Inc., a clinical-stage biotechnology company, develops antibody-drug conjugate (ADC) therapies to treat cancer. The company's product candidates include mirvetuximab soravtansine, an ADC targeting folate-receptor alpha (FRa), which is in Phase III clinical trial for the treatment of platinum-resistant ovarian cancer; and Pivekimab sun...

Get notified when there are updates to the investment portfolio of Quantitative Systematic Strategies LLC, based on Form 13F filings with the SEC.

Stay updated on Quantitative Systematic Strategies LLC with notifications on news.